Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Cash from Financing (Quarterly): 0.00 for Sept. 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.142M |
| March 31, 2023 | 49.49M |
| December 31, 2022 | 0.112M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.07M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 164.17M |
| September 30, 2021 | -1.483M |
| June 30, 2021 | 1.195M |
| March 31, 2021 | 99.89M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.483M
Minimum
Sep 2021
164.17M
Maximum
Dec 2021
28.51M
Average
0.112M
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 19.87M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.03M |
| Cash from Investing (Quarterly) | 10.08M |
| Free Cash Flow | -49.70M |
| Free Cash Flow Per Share (Quarterly) | -0.2529 |